Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting Myelodysplastic syndromes (MDS) ...
In patients suffering from myelodysplastic neoplasms (MDS), a group of often mildly progressing bone marrow disorders, the body does not produce enough functional blood cells. Affected individuals ...
Authors acknowledge that both the 2022 World Health Organization and International Consensus Classification myelodysplastic syndrome criteria sets have value, while sorting out their similarities and ...
Key opinion leaders discuss the impact MDS can have on the quality of life for patients compared with other hematologic disease states. Ryan Haumschild, PharmD, MS, MBA: I want to turn to Dr Zeidan.
Please provide your email address to receive an email when new articles are posted on . Individuals who smoked had more genetic mutations associated with myelodysplastic syndrome than nonsmokers.
The New Drug Application (NDA) for imetelstat in lower risk myelodysplastic syndromes (LR MDS), based on the results from the Phase 3 IMerge clinical trial, is currently under review by the United ...
Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and differentiation sustains healthy blood formation. In myelodysplastic ...
Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Abhay Singh, MD, MPH, of the Cleveland Clinic discusses the results of a study presented here on ...
In patients affected by myelodysplastic neoplasms (MDS), the body does not produce enough functional blood cells. Patients suffer from anaemia – a lack of red blood cells and haemoglobin – which can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results